67 related articles for article (PubMed ID: 2227635)
1. Central indwelling catheter to prevent phlebosclerosis by peptichemio in patients with multiple myeloma.
Luoni R; Ucci G; Riccardi A
Haematologica; 1990; 75(3):304. PubMed ID: 2227635
[No Abstract] [Full Text] [Related]
2. Alternating intravenous courses of melphalan and peptichemio in high-risk multiple myeloma (preliminary results).
Franchi F; Seminara P; Rossi Fanelli F
Anticancer Res; 1986; 6(2):297-8. PubMed ID: 3707066
[TBL] [Abstract][Full Text] [Related]
3. Peptichemio in multiple myeloma. (Preliminary results).
Cavo M; Gobbi M; Tura S
Haematologica; 1981 Apr; 66(2):208-15. PubMed ID: 6791997
[No Abstract] [Full Text] [Related]
4. Placement of hemodialysis catheters through stenotic or occluded central thoracic veins.
Haller C; Déglise S; Saucy F; Mathieu C; Haesler E; Doenz F; Corpataux JM; Qanadli SD
Cardiovasc Intervent Radiol; 2009 Jul; 32(4):695-702. PubMed ID: 19449059
[TBL] [Abstract][Full Text] [Related]
5. Peptichemio in pretreated patients with plasmacell neoplasms.
Paccagnella A; Salvagno L; Chiarion-Sileni V; Bolzonella S; De Besi P; Frizzarin M; Pappagallo GL; Fosser VP; Fornasiero A; Segati R
Eur J Cancer Clin Oncol; 1986 Sep; 22(9):1053-8. PubMed ID: 3780812
[TBL] [Abstract][Full Text] [Related]
6. Thrombosis of the superior vena cava and auxiliary branches in patients with indwelling catheterization of the internal jugular vein.
Li H; Wang SX; Wang W; Xu C; Shen S; Yu L; Zhang GZ
Chin Med J (Engl); 2009 Mar; 122(6):692-6. PubMed ID: 19323936
[TBL] [Abstract][Full Text] [Related]
7. Use of subcutaneous implantable infusion systems in neoplastic and AIDS patients requiring long-term venous access.
Dionigi P; Cebrelli T; Jemos V; Minoli L; Gobbi P; Dimitrov G
Eur J Surg; 1995 Feb; 161(2):137-42. PubMed ID: 7772631
[TBL] [Abstract][Full Text] [Related]
8. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
Fraenkel D; Rickard C; Thomas P; Faoagali J; George N; Ware R
Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
[TBL] [Abstract][Full Text] [Related]
9. Low inferior vena caval catheters for hemodynamic and pulmonary function monitoring in pediatric critical care patients.
Fernandez EG; Green TP; Sweeney M
Pediatr Crit Care Med; 2004 Jan; 5(1):14-8. PubMed ID: 14697103
[TBL] [Abstract][Full Text] [Related]
10. The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia.
Lorente L; Lecuona M; Ramos MJ; Jiménez A; Mora ML; Sierra A
Clin Infect Dis; 2008 Nov; 47(9):1171-5. PubMed ID: 18808356
[TBL] [Abstract][Full Text] [Related]
11. Acinetobacter infection in Hickman's catheterized patient of multiple myeloma.
Grover JK; Uppal G; Guleria R; Vats V; Raina V
J Assoc Physicians India; 2003 Oct; 51():1026-7. PubMed ID: 14719602
[No Abstract] [Full Text] [Related]
12. Rate of M-component changes and plasma cell labeling index in 25 patients with multiple myeloma treated with peptichemio.
Riccardi A; Montecucco C; Danova M; Ucci G; Merlini G; Ascari E
Cancer Treat Rep; 1985 Sep; 69(9):971-5. PubMed ID: 4028038
[TBL] [Abstract][Full Text] [Related]
13. Central venous catheter insertion by femoral vein: safety and effectiveness for the pediatric patient.
Kanter RK; Zimmerman JJ; Strauss RH; Stoeckel KA
Pediatrics; 1986 Jun; 77(6):842-7. PubMed ID: 3714376
[TBL] [Abstract][Full Text] [Related]
14. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients.
Kalfon P; de Vaumas C; Samba D; Boulet E; Lefrant JY; Eyraud D; Lherm T; Santoli F; Naija W; Riou B
Crit Care Med; 2007 Apr; 35(4):1032-9. PubMed ID: 17334256
[TBL] [Abstract][Full Text] [Related]
15. Indwelling central venous catheter--related infections and two different procedures of catheter care.
Jones PM
Cancer Nurs; 1987 Jun; 10(3):123-30. PubMed ID: 3502913
[No Abstract] [Full Text] [Related]
16. Contamination of central venous catheters in immunocompromised patients: a comparison between two different types of central venous catheters.
Stoiser B; Kofler J; Staudinger T; Georgopoulos A; Lugauer S; Guggenbichler JP; Burgmann H; Frass M
J Hosp Infect; 2002 Mar; 50(3):202-6. PubMed ID: 11886196
[TBL] [Abstract][Full Text] [Related]
17. External jugular venous catheterization with a Groshong catheter for central venous access.
Ishizuka M; Nagata H; Takagi K; Kubota K
J Surg Oncol; 2008 Jul; 98(1):67-9. PubMed ID: 18452215
[TBL] [Abstract][Full Text] [Related]
18. The timing and sequence of multiple device-related complications in patients with long-term indwelling Groshong catheters.
Tolar B; Gould JR
Cancer; 1996 Sep; 78(6):1308-13. PubMed ID: 8826955
[TBL] [Abstract][Full Text] [Related]
19. Rate of M-component changes and clinical course of 23 responsive myeloma patients.
Riccardi A; Montecucco C; Merlini G; Cremonini N; Danova M; Ascari E
Haematologica; 1984; 69(3):305-14. PubMed ID: 6432642
[No Abstract] [Full Text] [Related]
20. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M
Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
